Earlier this week, Sadev 94 signed a new promise of sale with Kadans Science Partner for a plot of land in the ZAC Campus (...)
According to Savills latest research, French capital invested in European real estate totalled nearly €3.2bn in H1 2023, accounting for 10% of all cross-border (...)
JLL has decided to set up a Life Sciences team in France. At the same time, the corporate real estate consultancy has also joined (...)
Life Sciences real estate - an asset class that encompasses the infrastructure occupied by the pharmaceutical, biotechnology and medical industries - has established itself (...)
After completing its first French acquisition in Villejuif at the end of 2022, Kadans Sciences Partners announced in mid-February its second French project, this (...)
After making its first real estate acquisition in France last year*, Kadans Science Partner has just signed a promise of sale with the EPA (...)
Kadans Science Partner has signed its first real estate acquisition in France, in Villejuif to be precise. The Axa IM Alts subsidiary has signed (...)
BiTV Interviews welcomes Michel Leemhuis, CEO and Co-owner at Kadans Science Partner. With him, we discuss the new 70,000 sqm building in London developped by his (...)
Paris-based global manager AXA IM Alts has raised €1.9bn of equity to accelerate investments into the Life Sciences sector. The capital raised will primarily (...)
Bought buy Axa IM Alts last autumn, Kadans Science Partner, has added The Sherard Building on Oxford Science Park, UK to its Pan-European portfolio. (...)
AXA Investment Managers announces a 6% increase in underlying earnings to €279m in 2020, driven by higher revenues. Revenues increased by 4% to €1,294m, (...)
Following its October $14.6bn recapitalisation of BioMed Realty, the largest private owner of life science office buildings in the United States, Blackstone announced in (...)
AXA Investment Managers - Real Assets has agreed to acquire, on behalf of clients, Kadans Science Partner, a fully integrated developer, owner and operator (...)